Moleculin Biotech, Inc. short interest in 2019
In 2019, Moleculin Biotech, Inc.'s disclosed short interest ran from 4.78% of shares outstanding on 15 Oct 2019 to 3.91% on 31 Dec 2019, a change of -0.87 percentage points. The year's high was 4.78% on 15 Oct 2019 and its low 3.91% on 31 Dec 2019, averaging 4.23% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 14.10 days on 15 Oct 2019. Full history: Moleculin Biotech, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2025
2019 in figures
- Start of year
- 4.78% (15 Oct 2019)
- End of year
- 3.91% (31 Dec 2019)
- Change
- -0.87 pp
- High
- 4.78% (15 Oct 2019)
- Low
- 3.91% (31 Dec 2019)
- Average
- 4.23%
- Highest days to cover
- 14.10 (15 Oct 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Oct 2019 | 4.78% | 14.10 | 10-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed, results (8-K) |
| 31 Oct 2019 | 4.28% | 10.91 | |
| 15 Nov 2019 | 4.14% | 10.69 | 10-Q filed, results (8-K) |
| 29 Nov 2019 | 4.10% | 8.84 | |
| 13 Dec 2019 | 4.18% | 7.90 | |
| 31 Dec 2019 | 3.91% | 5.52 |
See also: Moleculin Biotech, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.